Dennis M Mulvey

This inventor holds 6 USPTO granted patents. Top assignee: Ortho Pharmaceutical Corporation. Active years: 1984-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis M Mulvey. Retrieved from https://idiyas.com/inventor/dennis-m-mulvey-2crx488q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 34(Granted Patents)

Company Filing History:

6 out of 377

Ortho Pharmaceutical Corporation

patents

Years Active: 1984-1987

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4656267 - Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters (1987-04-07),

2. 4631283 - Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids (1986-12-23),

3. 4556739 - 3,4-Dialkoxy-2-alkylcarbonyl analino compounds (1985-12-03),

4. 4555571 - Substituted 2(1H)-quinazolinone-1-alkanoic acids and esters (1985-11-26),

5. 4555570 - Substituted 4-alkyl-2-(1H) quinazolinone-1-alkanoic acid derivatives (1985-11-26),

6. 4490374 - 5,6-Dialkoxy-3,4-optionally substituted-2(1H)quinazolinones, composition (1984-12-25),

Title: The Innovative Journey of Dennis M. Mulvey: A Pioneer in Cardiovascular Research

Introduction: Dennis M. Mulvey is a distinguished inventor based in New Hope, Pennsylvania, known for his significant contributions to the field of cardiovascular agents. With a total of six patents to his name, he has been instrumental in advancing medical science, particularly in the synthesis of novel compounds for renal vasodilation.

Latest Patents: Among his notable patents, Dennis's latest innovations include "Substituted 2(1H)-quinazolinone-1-alkanoic acids" and "Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids." The former describes the synthesis of quinazolinones that serve as renal vasodilators, reducing vascular resistance and improving renal blood flow. These compounds have promising applications as cardiovascular agents, indicating their potential to enhance patient outcomes in related medical treatments.

Career Highlights: Dennis M. Mulvey's career at Ortho Pharmaceutical Corporation has been marked by his relentless pursuit of innovation. His work has not only led to the development of new therapeutic agents but has also reinforced the importance of research and development in the pharmaceutical industry. His patents are a testament to his ingenuity and dedication to improving healthcare through scientific advancements.

Collaborations: Throughout his career, Dennis has collaborated with notable colleagues, including Victor T. Bandurco and Seymour D. Levine. These partnerships have enriched his research endeavors and contributed to the successful development of his patented inventions, showcasing the power of teamwork in scientific innovation.

Conclusion: Dennis M. Mulvey stands as a prominent figure in the realm of medical inventions, particularly in the cardiovascular field. His dedication to research and his innovative patents have made a lasting impact in the pharmaceutical industry. As he continues to explore new scientific frontiers, his work remains a source of inspiration for emerging inventors and researchers alike.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]